Navigation Links
Study Shows Cholera Can be Controlled With Oral Vaccines
Date:11/26/2007

SEATTLE, Nov. 26 /PRNewswire/ -- Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle. Longini and colleagues will report their findings online Nov. 27 in PLoS Medicine.

While oral cholera vaccines have been available to protect travelers for more than a decade, they have not been used for widespread control of the disease in cholera-prone (endemic) regions in part because their protective potential has been underestimated. In fact, using a computer simulation model based on data from a large-scale cholera-vaccine trial involving 200,000 people in Matlab, Bangladesh, Longini and colleagues suggest that internationally licensed, killed whole-cell cholera vaccines (OCVs) may be highly effective in controlling cholera when given via mass immunization.

Longini and colleagues estimate that cholera cases could be reduced nearly 90 percent among the unvaccinated if just 50 percent of the population received an oral vaccination biannually. Vaccinating just 30 percent of the population every two years would achieve an overall cholera reduction rate of 76 percent. In populations with less experience with cholera than Matlab, at least 70 percent of the population would need to be vaccinated to control the disease.

"This is the first scientific work that shows how we could control cholera on a global level," said Longini, also a professor of biostatistics at the University of Washington School of Public Health and Community Medicine. "Once you get up to about 50 percent of the population vaccinated, you can drive the epidemic into practically nothing."

Endemic cholera is a bacterial infection of the small intestine that causes acute, watery diarrhea. If untreated, it can lead to potentially fatal dehydration. Although advances in rehydration therapy have made cholera a treatable disease in areas with sufficient medical care, it remains a fatal condition among the world's most impoverished populations. The disease is caused by ingesting food or water contaminated with a comma-shaped bacterium called Vibrio cholerae.

Co-authors on the paper included researchers from Emory University in Atlanta; the International Vaccine Institute in Seoul, Korea; and the International Centre for Diarrhoeal Disease Research in Bangladesh.

"These important findings stem from the recent recognition that oral vaccines against cholera confer herd protection -- protection of nonvaccinated neighbors of vaccinated persons," said John Clemens, M.D., director-general of the International Vaccine Institute and paper co-author. "I believe this study will have an impact on the public-health community's approach to controlling cholera," he said.

The research was supported by the Diseases of the Most Impoverished (DOMI) Program of the Bill & Melinda Gates Foundation, a grant from the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS), and the U.S. National Institute of Allergy and Infectious Diseases.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

PLoS Medicine is an open-access journal. Everything it publishes is freely available for anyone to read, download, distribute and re-use. Below is a link to the PLoS Medicine paper "Controlling endemic cholera with oral vaccines" by Longini and colleagues: http://medicine.plosjournals.org/perlserv/?request=get- document&doi=10.1371/journal.pmed.0040336

CONTACT

Kristen Woodward

(206) 667-5095

kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 04, 2016 , ... IsoComforter, Inc., one of the Nations ... newly improved Iso-Hip Wrap. The newly designed hip wrap has been specifically ... enables the patient to enjoy the benefits of cold therapy while resting, sitting, ...
(Date:5/4/2016)... ... May 04, 2016 , ... A new collaboration will give ... Duke Clinical Research Institute (DCRI) and analytics leader SAS will provide researchers worldwide with ... by the Duke University Health System. , The DCRI and SAS share the ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Francesca Loparco, Co-Founder ... her life forever with a same-day LASIK procedure at Christenbury Eye Center. ... Dr. Jonathan Christenbury performed her surgery the same day as her in-office consultation and ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Advanced ... technology to help restore its patients’ health, is hosting a free seminar on stem ... will be held at Advanced Spine & Sport, 4601 Telephone Road, Suite 110, Ventura, ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016  It,s time for an upgrade. There are many medical ... brilliant 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  ... as a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
(Date:5/4/2016)... 2016 Research and ... Acute Myeloid Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia ...
Breaking Medicine Technology: